When we published our Five Tips for Choosing a Statistical Computing Environment back in 2023, the conversation was about what to look for. If you’re evaluating how to select a statistical computing environment, start with this overview. The following post focuses on what has changed and what a modern SCE makes possible.
The conversation around statistical computing environments (SCEs) has moved from what to look for to what’s now possible.
Three years ago, we laid out a framework for evaluating statistical computing environments. The five considerations – security, openness, reproducibility, accessibility and future-readiness – haven’t changed. They reflected the real tensions that life sciences organizations wrestle with every day: between protecting sensitive data and enabling collaboration, between regulatory rigor and research agility and between what works today and what the future demands.
The distance between where we were in 2023 and where we are today is not a step forward. It’s a leap. Susan Lenderts, SVP, Head of Global Life Sciences & Health Care, SAS
What’s different now is how those capabilities are delivered. What once required tradeoffs and workarounds can now exist in a single, unified environment.
With the launch of SAS® Clinical Acceleration – a cloud-native platform that combines a secure clinical data repository with a statistical computing environment built on SAS® Viya® – we’re seeing that shift play out in practice.
And looking back at those five considerations, it's remarkable how much things have shifted – not just incrementally, but fundamentally.
What is a modern statistical computing environment?
A modern SCE is a governed, multilanguage analytical environment that unifies data access, security, reproducibility and AI-ready workflows across the clinical life cycle. Critically, it does this without forcing organizations to choose between speed and compliance, between openness and control, or between today’s needs and tomorrow’s demands.
1. Security is still the bedrock and now it's built in, not bolted on
Data privacy and security remain non-negotiable. It must be the foundation of any viable SCE. What has changed is the expectation: security is now something platforms deliver by design.
SAS Clinical Acceleration provides a production-ready clinical data repository with role-based access control, electronic signatures, version control and full audit trails, all baked into the platform. Compliance with 21 CFR Part 11 of the FDA is a design principle.
The result is an environment where every action is auditable, every decision is traceable, and every regulatory reviewer can follow the data lineage without friction. That's not just good governance, it’s a market differentiator that compounds over time. Organizations that build on a foundation of embedded compliance move faster, remediate less and earn regulatory trust at scale.
2. The "either/or" era of security vs. openness is over
For too long, organizations accepted that more security meant less flexibility – and more flexibility meant more risk. That tradeoff is disappearing. It’s indeed a collapse of the false choice between a locked-down environment and one that works for your team.
SAS Clinical Acceleration supports analyses in SAS, R and Python within a single governed environment. This is the "bring your own language" capability that executives have been asking for – and it matters enormously at the organizational level.
A biostatistician who has spent a career in SAS, a data scientist who lives in Python, a researcher who prefers R: they can all operate on the same platform, within the same compliance guardrails, contributing to the same regulatory submission.
That kind of inclusivity eliminates the shadow IT problem that creates massive waste and budgetary risks and gives leadership a platform they can actually bet on and fully trust.
3. Reproducibility is no longer a goal – it's a guarantee
We wrote previously about this nightmare scenario: running an analysis twice and getting two different answers. It's not hypothetical. It has delayed submissions, undermined findings and in some cases derailed entire programs.
The modern SCE removes that uncertainty. SAS Clinical Acceleration is built around auditable actions, data traceability and repeatable analyses by design. Every step is documented, versioned and recoverable.
Researchers can confidently hand off work to regulators knowing that what they see is exactly what was produced – and that it can be reproduced on demand. In an environment where a single inconsistency can cost months of remediation, that level of confidence changes everything.
4. Accessibility for all users is a force multiplier
Statisticians remain central to the SCE. But we've also learned, time and again, that breakthroughs happen at the edges – more stakeholders can engage meaningfully with the data without needing a programming degree.
SAS Clinical Acceleration is designed for all user types. No-code and low-code interfaces enable non-technical stakeholders to navigate and explore clinical data intuitively, while quantitative experts retain the depth and control they require.
Sponsors, contract research organizations and regulatory bodies can collaborate on a shared platform with a single source of truth, something that has historically required significant organizational gymnastics. When everyone is working from the same data in the same governed space, the pace of progress accelerates in ways hard to overstate.
For expert users, accessibility also means flexibility. With Proc R capabilities in SAS Clinical Acceleration, R users can work in their preferred language without leaving the governed environment. No exporting data, no recreating controls or operating parallel systems – just continuous, connected workflows. The result is fewer handoffs, less rework and far greater confidence that everyone is working from the same source of truth.
5. The future isn't coming, it's already here
AI is no longer a future consideration for SCEs. AI powers how work gets done. Before, building with AI and machine learning in mind was forward-looking advice. Today, it’s the minimum threshold. SAS didn’t just meet this threshold; we built well beyond it.
SAS Clinical Acceleration supports generative AI, AI agents, large language models (LLMs), digital twins and synthetic data in a transparent and explainable way. Organizations are deploying these capabilities now to compress timelines, improve data quality and surface insights that once took months to uncover.
The modern SCE eliminates those delays at scale.
The stakes are too high for yesterday's tools
Looking back at the 2023 framework, what strikes me most is not how much has changed, but how consistent the underlying goals have always been: protect the data, trust the results, work across teams and stay ahead of what's next.
Those goals haven't changed. Now, a purpose-built platform achieves all of them simultaneously, without the tradeoffs that once felt inevitable.
SAS Clinical Acceleration is not just a better SCE. It is the modern SCE; it is the defining SCE of this era. It sets the standard for what governed, AI-ready, multi-language clinical computing looks like in practice. And it gives organizations the confidence to move faster, submit with greater certainty, and ultimately serve the patients who are waiting and counting on us on the other side of every submission.
In 2023, the question was: What should you look for in an SCE? In 2026, the question is: what are you waiting for?
